Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
Share on Pinterest A new study links dairy products with a reduced risk of developing type 2 diabetes and red and processed meats with a higher risk. Wanwisa Hernandez/EyeEm/Getty Images About 90–95% ...
March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...